Carey D. Kimmelstiel, MD
Academic Title:
Associate Professor, Tufts University School of Medicine
Division/Program Title:
Director, Adult Cardiac Catheterization Laboratory and Interventional Cardiology
Director, Clinical Cardiology
Office:
800 Washington St., #264 Boston, MA 02111
Phone:
617-636-5914
Accepting New Patients
Fax:
617-636-5913
Email Address:
ckimmelstiel@tuftsmedicalcenter.org
Education and Post Graduate Training:
Medical School: State University of New York Downstate College of Medicine, Brooklyn, NY- 1982
Residency: Kings County Hospital/University Hospital, Downstate Health Sciences Center, Brooklyn, NY - 1982-85
Chief Resident: Kings County Hospital/University Hospital, Downstate Health Sciences Center, Brooklyn, NY – 1985-86
Cardiology Fellowship: University of Massachusetts Medical Center, Worcester, MA – 1986-89
Interventional Cardiology/Heart Failure Fellowship: Tufts-New England Medical Center, Boston, MA – 1989-90
Board Certifications:
Interventional Cardiology, Cardiovascular Disease, Internal Medicine
Specialties:
Cardiology Medicine
Interventional cardiology
Clinical Interests:
Interventional cardiology
Research Interests:
Adjunctive therapy for percutaneous coronary intervention
Structural heart disease
Septal ablation for hypertrophic cardiomyopathy
Selected Publications:
-
Kimmelstiel C, Phang R, Rehman A, et al. Outcomes following the use of different GP IIb/IIIa antagonists in patients undergoing coronary intervention. J Thrombos and Thrombolys 2001;11:203-9.
-
Kimmelstiel CD, Maron BJ. Percutaneous septal ablation in hypertrophic cardiomyopathy. Circulation 2004; 109:452-56.
-
Kimmelstiel C, Levine D, Perry K, et al. Randomized, controlled evaluation of short- and long-term benefits of heart failure disease management within a diverse provider network: The SPAN-CHF Trial. Circulation 2004;110:1450-55.
-
Kimmelstiel C, Badar J, Covic L, et al. Pharmacodynamics and pharmacokinetics of the platelet GPIIb/IIIa inhibitor tirofiban in patients undergoing percutaneous coronary intervention: implications for adjustment of tirofiban and clopidogrel dosage. Thromb Res 2005;116:55-66.
-
Kimmelstiel C, Gange C, Thaler DE. Is PFO Closure effective in reducing migraine symptoms? A controlled study. Cath Cardiovasc Intervent 2007; 69:740–46.
Honors/Awards:
Professional Affiliations:
American College of Cardiology – Fellow
American College of Physicians – Fellow
Society for Cardiac Angiography and Interventions- Fellow
American Heart Association- Member
AHA Council on Clinical Cardiology- Member
Massachusetts Medical Society- Member
Foreign Languages:
Gender:
M
|